NDC 82454-0371

PROVAYBLUE

Methylene Blue

PROVAYBLUE is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Cenexi Hsc. The primary component is Methylene Blue.

Product ID82454-0371_d3379939-6ce8-2e97-e053-2995a90a8755
NDC82454-0371
Product TypeHuman Prescription Drug
Proprietary NamePROVAYBLUE
Generic NameMethylene Blue
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-04-08
Marketing CategoryNDA /
Application NumberNDA204630
Labeler NameCENEXI HSC
Substance NameMETHYLENE BLUE
Active Ingredient Strength5 mg/mL
Pharm ClassesOxidation-Reduction Activity [MoA],Oxidation-Reduction Agent [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 82454-0371-5

5 VIAL, SINGLE-DOSE in 1 CARTON (82454-0371-5) > 2 mL in 1 VIAL, SINGLE-DOSE (82454-0371-1)
Marketing Start Date2021-12-31
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "PROVAYBLUE" or generic name "Methylene Blue"

NDCBrand NameGeneric Name
0517-0125PROVAYBLUEmethylene blue
0517-0371PROVAYBLUEmethylene blue
0517-0374PROVAYBLUEmethylene blue
0517-0381PROVAYBLUEmethylene blue
82454-0125PROVAYBLUEmethylene blue
82454-0371PROVAYBLUEmethylene blue
82454-0374PROVAYBLUEmethylene blue
82454-0381PROVAYBLUEmethylene blue
17478-504Methylene BlueMethylene Blue
52584-504Methylene BlueMethylene Blue
54288-147Methylene BlueMethylene Blue

Trademark Results [PROVAYBLUE]

Mark Image

Registration | Serial
Company
Trademark
Application Date
PROVAYBLUE
PROVAYBLUE
86930634 5242388 Live/Registered
PROVEPHARM LIFE SOLUTIONS
2016-03-07
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.